Search Results 13011-13020 of 40311 for oral

  1. Potential Cancer Treatment Advance Using Ionic Liquid - Mayo Clinic News Network

    Targeted therapies, also called local-regional therapy, are ones that use extreme heat or cold, radiation, or chemotherapy to destroy tumor cells.

  2. Parathyroidectomy - Doctors & Departments - Mayo Clinic

    Payam Entezami, M.D., M.S.. Otolaryngologist. Phoenix, AZ. Areas of focus: Fine needle aspiration, Oral surgery, Transoral robotic surgery, Parotid gland ...

  3. Sarcoma - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Salivary gland cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Melanoma, Tonsil cancer, Skin cancer, Squamous cell ...

  4. Sarcoma - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Head and neck cancer, Skin cancer, Oropharyngeal cancer, Mouth cancer, Thyroid cancer, Melanoma, Squamous cell carcinoma of the skin ...

  5. Obstructive sleep apnea - Doctors and departments - Mayo Clinic

    Departments that treat this condition · Dental Specialties · Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep Medicine ...

  6. Thyroid nodules - Doctors and departments - Mayo Clinic

    ... Oral surgery, Salivary gland surgery, Throat cancer, Salivary gland cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Melanoma, Tonsil cancer ...

  7. A Phase 1b/2 Study of Onvansertib (PCM-075) in Combination with FOLFIRI and Bevacizumab for Second-Line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS Mutation - Mayo Clinic

    Gastrointestinal (GI) disorder(s) that, in the opinion of the Investigator, would significantly impede the absorption of an oral agent (e.g., intestinal ...

  8. Phase II Trial of Irinotecan, Cetuximab, and Bevacizumab Compared With Irinotecan, Cetuximab, and Placebo in KRAS-Wildtype, Irinotecan-Refractory, Metastatic Colorectal Cancer - Mayo Clinic

    Women who are using oral, implanted, or injectable contraceptive hormones or mechanical products such as intrauterine device or barrier methods (diaphragm ...

  9. A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer - Mayo Clinic

    Ability to swallow oral medication. Adequate bone marrow function (Platelets ≥100x10^9/L; Absolute Neutrophil Count (ANC) ≥ 1.5x10^9/L and Haemoglobin ...

  10. Cenobamate Adjunctive Therapy for Primary Generalized Tonic-Clonic Seizures - Mayo Clinic

    Previous exposure to cenobamate or sensitivity/allergy to components of the oral suspension. Any potential exception to the inclusion as well as exclusion ...